Arash Salardini, MD, associate professor of cognitive and behavioral neurology with the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was quoted in this article. Read More
Share This Story
Sudha Seshadri, MD, founding director of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, and Arash Salardini, MD, associate professor of cognitive and behavioral neurology with the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, were quoted in this article. Read More
Share This Story
Arash Salardini, MD, associate professor of cognitive and behavioral neurology with the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, and Sudha Seshadri, MD, founding director of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, were quoted in this article. Read More
Share This Story
Arash Salardini, MD, associate professor of cognitive and behavioral neurology with the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was mentioned in this article. Read More
Share This Story
Can stress lead to Alzheimer’s disease? It can in women who are post-menopausal, a study led by The University of Texas Health Science Center at San Antonio (UT Health San Antonio) shows. Analyzing data from 305 cognitively unimpaired participants in the Framingham Heart Study, a long-term and ongoing community-based cohort study of residents in […]
Share This Story
Hong-yu Li, PhD, Department of Pharmacology and the Sam and Ann Barshop Institute for Longevity and Aging Studies, was quoted in this article. Read More
Share This Story
Wei Liu, PhD, associate professor, Department of Physical Therapy, and research director of Rehabilitation, Integrative and Complementary Health, was quoted in this article, and Lixin Song, PhD, professor and vice dean of research and scholarship, School of Nursing, was mentioned. Read More
Share This Story
Sudha Seshadri, MD, professor and founding director of the Glenn Biggs Institute for Alzheimer’s and Neurogenerative Diseases, and Michael Charlton, PhD, senior vice president of Facilities and Capital Planning and chief facility planning officer, were interviewed for this article. Read More
Share This Story
Major breakthrough could redefine drug discovery, broaden options A research team led by scientists at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) made a major breakthrough with the potential to turn IV drugs into oral treatments for diseases like brain cancer and Alzheimer’s disease. The discovery could reshape how medicines […]
Share This Story
Robert A. Hromas, MD, FACP, dean of the Joe R. and Teresa Lozano Long School of Medicine, was quoted in this article. Read More
Share This Story